PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT: directors' dealings · Italy · Consob

Explore the full management transaction log of PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT, a listed equity based in Italy. Shares are quoted on IT IT, under the authority of Consob. Operating in the Healthcare sector, PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT has logged 1 public disclosures. Market capitalisation: €861.8m. The latest transaction was filed on 17 July 2023 — Other. Among the most active insiders: Unknown. All data is free.